Literature DB >> 17994216

Proliferation of sorted human and rat beta cells.

G Parnaud1, D Bosco, T Berney, F Pattou, J Kerr-Conte, M Y Donath, C Bruun, T Mandrup-Poulsen, N Billestrup, P A Halban.   

Abstract

AIMS/HYPOTHESIS: The aim of the study was to determine whether purified beta cells can replicate in vitro and whether this is enhanced by extracellular matrix (ECM) and growth factors.
METHODS: Human beta cells were purified by FACS by virtue of their high zinc content using Newport Green, and excluding ductal and dead cells. Rat beta cells were sorted by autofluorescence or using the same method developed for human cells. Cells were plated on poly-L-lysine or ECMs from rat or human bladder carcinoma cells or bovine corneal ECM and incubated in the presence of BrdU with or without growth factors.
RESULTS: The newly developed method for sorting human beta cells yields a population containing 91.4 +/- 2.8% insulin-positive cells with a low level of spontaneous apoptosis and a robust secretory response to glucose. Beta cells from 8-week-old rats proliferated in culture and this was increased by ECM. Among growth factors, only human growth hormone (hGH) and the glucagon-like peptide-1 analogue liraglutide enhanced proliferation of rat beta cells, with a significant increase on both poly-L-lysine and ECM. By contrast, sorted adult human beta cells from 16 donors aged 48.9 +/- 14.3 years (range 16-64 years) failed to replicate demonstrably in vitro regardless of the substratum or growth factors used. CONCLUSIONS/
INTERPRETATION: These findings indicate that, in our conditions, the fully differentiated human adult insulin-producing beta cell was unable to proliferate in vitro. This has important implications for any attempt to expand cells from pancreases of donors of this age group. By contrast, the rat beta cells used here were able to divide in vitro, and this was enhanced by ECM, hGH and liraglutide.

Entities:  

Mesh:

Year:  2007        PMID: 17994216     DOI: 10.1007/s00125-007-0855-1

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  46 in total

1.  Expansion and redifferentiation of adult human pancreatic islet cells.

Authors:  Limor Ouziel-Yahalom; Michal Zalzman; Leeat Anker-Kitai; Sarah Knoller; Yael Bar; Mariela Glandt; Kevan Herold; Shimon Efrat
Journal:  Biochem Biophys Res Commun       Date:  2006-01-19       Impact factor: 3.575

2.  Endocrine precursor cells from mouse islets are not generated by epithelial-to-mesenchymal transition of mature beta cells.

Authors:  Russell A Morton; Elizabeth Geras-Raaka; Leah M Wilson; Bruce M Raaka; Marvin C Gershengorn
Journal:  Mol Cell Endocrinol       Date:  2007-02-15       Impact factor: 4.102

3.  Isolation of rat pancreatic islets by ductal injection of collagenase.

Authors:  R Sutton; M Peters; P McShane; D W Gray; P J Morris
Journal:  Transplantation       Date:  1986-12       Impact factor: 4.939

4.  Aging correlates with decreased beta-cell proliferative capacity and enhanced sensitivity to apoptosis: a potential role for Fas and pancreatic duodenal homeobox-1.

Authors:  Kathrin Maedler; Desiree M Schumann; Fabienne Schulthess; José Oberholzer; Domenico Bosco; Thierry Berney; Marc Y Donath
Journal:  Diabetes       Date:  2006-09       Impact factor: 9.461

5.  Growth hormone- and prolactin-induced proliferation of insulinoma cells, INS-1, depends on activation of STAT5 (signal transducer and activator of transcription 5).

Authors:  B N Friedrichsen; E D Galsgaard; J H Nielsen; A Møldrup
Journal:  Mol Endocrinol       Date:  2001-01

6.  A novel approach to increase human islet cell mass while preserving beta-cell function.

Authors:  Gillian M Beattie; Anthony M P Montgomery; Ana D Lopez; Ergeng Hao; Brandon Perez; Margaret L Just; Jonathan R T Lakey; Marquis E Hart; Alberto Hayek
Journal:  Diabetes       Date:  2002-12       Impact factor: 9.461

7.  Culture of adult human islet preparations with hepatocyte growth factor and 804G matrix is mitogenic for duct cells but not for beta-cells.

Authors:  V H Lefebvre; T Otonkoski; J Ustinov; M A Huotari; D G Pipeleers; L Bouwens
Journal:  Diabetes       Date:  1998-01       Impact factor: 9.461

8.  Pancreatic morphogenesis and extracellular matrix organization during rat development.

Authors:  M Hisaoka; J Haratake; H Hashimoto
Journal:  Differentiation       Date:  1993-07       Impact factor: 3.880

9.  Rapid purification of human ductal cells from human pancreatic fractions with surface antibody CA19-9.

Authors:  Valéry Gmyr; Sandrine Belaich; Ghaffar Muharram; Bruno Lukowiak; Brigitte Vandewalle; François Pattou; Julie Kerr-Conte
Journal:  Biochem Biophys Res Commun       Date:  2004-07-16       Impact factor: 3.575

10.  Stimulation of pancreatic beta-cell replication by incretins involves transcriptional induction of cyclin D1 via multiple signalling pathways.

Authors:  Birgitte N Friedrichsen; Nicole Neubauer; Ying C Lee; Vivian K Gram; Niels Blume; Jacob S Petersen; Jens H Nielsen; Annette Møldrup
Journal:  J Endocrinol       Date:  2006-03       Impact factor: 4.286

View more
  117 in total

1.  Human beta cell proliferation by glucose--a complex scenario.

Authors:  M Tiedge
Journal:  Diabetologia       Date:  2010-12-21       Impact factor: 10.122

2.  Expanding human beta cells.

Authors:  R Scharfmann
Journal:  Diabetologia       Date:  2008-02-15       Impact factor: 10.122

3.  Signaling pathways implicated in the stimulation of beta-cell proliferation by extracellular matrix.

Authors:  Géraldine Parnaud; Eva Hammar; Pascale Ribaux; Marc Y Donath; Thierry Berney; Philippe A Halban
Journal:  Mol Endocrinol       Date:  2009-05-14

4.  A simple two-step protocol for the purification of human pancreatic beta cells.

Authors:  M Banerjee; T Otonkoski
Journal:  Diabetologia       Date:  2009-01-24       Impact factor: 10.122

5.  Early and Late G1/S Cyclins and Cdks Act Complementarily to Enhance Authentic Human β-Cell Proliferation and Expansion.

Authors:  Shiwani Tiwari; Chris Roel; Rachel Wills; Gabriella Casinelli; Mansoor Tanwir; Karen K Takane; Nathalie M Fiaschi-Taesch
Journal:  Diabetes       Date:  2015-07-09       Impact factor: 9.461

Review 6.  The pancreatic β-cell transcriptome and integrated-omics.

Authors:  David M Blodgett; Anthony J Cura; David M Harlan
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2014-04       Impact factor: 3.243

Review 7.  Advances in β cell replacement and regeneration strategies for treating diabetes.

Authors:  Jacqueline R Benthuysen; Andrea C Carrano; Maike Sander
Journal:  J Clin Invest       Date:  2016-10-03       Impact factor: 14.808

8.  Altering β-cell number through stable alteration of miR-21 and miR-34a expression.

Authors:  Marie Balslev Backe; Guy Wayne Novotny; Dan Ploug Christensen; Lars Groth Grunnet; Thomas Mandrup-Poulsen
Journal:  Islets       Date:  2014       Impact factor: 2.694

9.  Increased interleukin (IL)-1beta messenger ribonucleic acid expression in beta -cells of individuals with type 2 diabetes and regulation of IL-1beta in human islets by glucose and autostimulation.

Authors:  Marianne Böni-Schnetzler; Jeffrey Thorne; Géraldine Parnaud; Lorella Marselli; Jan A Ehses; Julie Kerr-Conte; Francois Pattou; Philippe A Halban; Gordon C Weir; Marc Y Donath
Journal:  J Clin Endocrinol Metab       Date:  2008-07-29       Impact factor: 5.958

10.  Autonomous and self-sustained circadian oscillators displayed in human islet cells.

Authors:  P Pulimeno; T Mannic; D Sage; L Giovannoni; P Salmon; S Lemeille; M Giry-Laterriere; M Unser; D Bosco; C Bauer; J Morf; P Halban; J Philippe; C Dibner
Journal:  Diabetologia       Date:  2012-12-15       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.